Insiders · Profile

Stout Jay S

Chief Technology Officer at Immunovant. Filing since 24 Apr 2024. CIK 0001702969

Company
Date
Role
Action
Shares
Amount
Of holding
7 Oct 2026
Chief Technology Officer
Sold at will
3,809
$122.12K
1.9%
23 Jul 2026
Chief Technology Officer
Sold at will
2,857
$110.54K
1.4%
8 Jul 2026
Chief Technology Officer
Sold at will
3,487
$137.92K
1.6%
26 Jun 2026
Chief Technology Officer
Sold at will
40,000
$1.53M
15.9%
23 Apr 2026
Chief Technology Officer
Sold at will
2,754
$81.57K
1.1%
8 Apr 2026
Chief Technology Officer
Sold at will
10,132
$251.58K
3.8%
21 Jan 2026
Chief Technology Officer
Sold at will
1,977
$51.46K
1.0%
7 Jan 2026
Chief Technology Officer
Sold at will
1,203
$31.91K
0.6%
22 Oct 2025
Chief Technology Officer
Sold at will
2,520
$47.96K
1.2%
8 Oct 2025
Chief Technology Officer
Sold at will
1,585
$25.84K
0.8%
23 Jul 2025
Chief Technology Officer
Sold at will
2,805
$50.91K
1.4%
9 Jul 2025
Chief Technology Officer
Sold at will
1,519
$26.19K
0.7%
23 Apr 2025
Chief Technology Officer
Sold at will
1,925
$28.47K
0.9%
9 Apr 2025
Chief Technology Officer
Sold at will
5,004
$65.00K
2.3%
22 Jan 2025
Chief Technology Officer
Sold at will
2,195
$51.78K
1.5%
23 Oct 2024
Chief Technology Officer
Sold at will
2,740
$80.91K
1.9%
24 Jul 2024
Chief Technology Officer
Sold at will
2,813
$78.09K
1.9%
24 Apr 2024
Chief Technology Officer
Sold at will
7,239
$209.21K
4.7%
18 decisions on file.